Abbreviations
GLIOMATCH is a 5-year EU-funded research project focused on using state-of-the-art technology to better understand how immunotherapy can be used to treat brain tumours in adults and children. To make our research more accessible, we’ve started the GLIOMATCH: Explained series. These short video interviews feature conversations with experts and clinicians on key project topics. Through this series, we aim to bring complex scientific research closer to a wider audience across Europe and beyond.
Welcome to the first episode of GLIOMATCH: Explained. In this episode, Prof. Frederik De Smet (KUL), GLIOMATCH project coordinator, breaks down the project’s objectives, innovation, and overall structure